SRM-IV眩晕诊疗系统治疗良性阵发性位置性眩晕的疗效观察

doi:10.3969/j.issn.1006-6233.2025.05.024

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To observe the efficacy of SRM-IV vertigo diagnosis and treatment system in the treatment of benign paroxysmal positional vertigo (BPPV). Methods: A total of 154 patients with BPPV in the hospital were enrolled from July 2023 to July 2024, and were divided into control group (manipulative reduction treatment) and instrument reduction group (SRM-IV vertigo diagnosis and treatment system) by random number table method. The therapeutic effect, vertigo degree [Dizziness Handicap Inventory (DHI)], vestibular function [Vestibular Activities of Daily Living (VADL), Vestibular Symptom Index (VSI)] and balance function [Berg Balance Scale (BBS)] before and after treatment were compared between groups, and the incidence rate of adverse reactions and occurrence of residual dizziness (RD) within 1 month of follow-up were counted. Results: The total effective rate in instrument reduction group was higher than that in control group (P<0.05). After treatment, the scores of VADL,DHI and VSI scales in the two groups were decreased, the BBS score in both groups was risen, and the difference value before and after treatment in instrument reduction group was significantly greater than that in control group (P<0.05). there was no statistical difference in the incidence rate of adverse reactions between groups (P>0.05). Within 1 month of follow-up, the incidence rate and duration of RD in instrument reduction group were significantly lower or shorter compared to control group (P<0.05). Conclusion: SRM-IV vertigo diagnosis and treatment system has significant efficacy in the treatment of BPPV, and it can effectively improve the vertigo degree, vestibular function and balance function, and reduce the occurrence of RD symptoms, and it has good safety.

Key words： SRM-IV vertigo diagnosis and treatment system Benign paroxysmal positional vertigo Vestibular function Efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2025.05.024 OR http://www.hbyxzzs.cn/EN/Y2025/V31/I5/838

[1] Cole SR,Honaker JA.Benign paroxysmal positional vertigo:effective diagnosis and treatment[J].Cleve Clin Med,2022,89(11):653-662.
[2] Rogers TS,Noel MA,Garcia B.Dizziness:evaluation and management[J].Am Fam Physician,2023,107(5):514-523.
[3] Power L,Murray K,Szmulewicz DJ.Characteristics of assessment and treatment in Benign Paroxysmal Positional Vertigo (BPPV)[J].Vestib Res,2020,30(1):55-62.
[4] 马福然,王金平,姜子刚.SRM-IV眩晕诊疗系统序惯治疗后半规管嵴顶结石症疗效观察[J].神经损伤与功能重建,2021,16(8):485-486.
[5] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.良性阵发性位置性眩晕诊断和治疗指南(2017)[J].中华耳鼻咽喉头颈外科杂志,2017,52(3):173-177.
[6] 丁雷,刘畅,王嘉玺,等.眩晕残障程度评定量表(中文版)的评价[J].中华耳科学杂志,2013,11(2):228-230.
[7] Xu XD,Luo HP,Jie JQ,et al.Chinese version of the vestibular disorders activities of daily living scale[J].Laryngoscope,2022,132(7):1446-1451.
[8] 中华医学会神经病学分会,中华神经科杂志编辑委员会.眩晕诊治专家共识[J].中华神经科杂志,2010,43(5):369-374.
[9] 杨玉洁,刘慧勤,王艳,等.3种跌倒风险评估量表在视神经脊髓炎谱系疾病患者中应用的信效度及预测价值分析[J].护士进修杂志,2023,38(5):396-400.
[10] Imai T,Inohara H.Benign paroxysmal positional vertigo[J].Auris Nasus Larynx,2022,49(5):737-747.
[11] Strupp M,Mandala M,Vinck AS,et al.The semont-plus maneuver or the epley maneuver in posterior canal benign paroxysmal positional vertigo:a randomized clinical study[J].JAMA Neurol,2023,80(8):798-804.
[12] 赵颖,王利军,李伟,等.SRM-IV眩晕诊疗系统联合倍他司汀治疗半规管耳石症致前庭周围性眩晕的效果分析[J].河北医科大学学报,2022,43(9):1062-1067.
[13] 徐铭蔚,姚远,吴琼,等.外周前庭系统功能异常对儿童大动作发育的影响[J].中华医学杂志,2024,104(14):1196-1201.
[14] Cetin YS,Cagac A,Duzenli U,et al.Residual dizziness in elderly patients after benign paroxysmal positional vertigo[J].ORL Otorhinolaryngol Relat Spec,2022,84(2):122-129.